The Ikaros Transcription Factor Regulates Responsiveness to IL-12 and Expression of IL-2 Receptor Alpha in Mature, Activated CD8 T Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Clambey, Eric T ^a,b,c   Collins, Bernard ^a,b,d   Young, Mary H ^a,b   Eberlein, Jens ^a,c   David, Alexandria ^a,b   Kappler, John W ^a,b,c   Marrack, Philippa ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOS TRANSCRIPTION FACTOR; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR ALPHA; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN;

ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN-12; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 84874505279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057435     Document Type: Article

References (70)

1. Kaech SM, Wherry EJ, Ahmed R, (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2: 251-262.
2. Kaech SM, Wherry EJ, (2007) Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27: 393-405.
3. Georgopoulos K, (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2: 162-174.
4. Sun L, Liu A, Georgopoulos K, (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. Embo J 15: 5358-5369.
5. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, et al. (1994) The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156.
6. Molnar A, Georgopoulos K, (1994) The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14: 8292-8303.
7. Roberts KG, Mullighan CG, (2011) How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia. Curr Opin Pediatr 23: 34-40.
8. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, et al. (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
9. Urban JA, Winandy S, (2004) Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions. J Immunol 173: 4470-4478.
10. Avitahl N, Winandy S, Friedrich C, Jones B, Ge Y, et al. (1999) Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 10: 333-343.
11. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW, (2012) Helios expression is a marker of T cell activation and proliferation. PLoS One 6: e24226.
12. Bandyopadhyay S, Dure M, Paroder M, Soto-Nieves N, Puga I, et al. (2007) Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 109: 2878-2886.
13. Thomas RM, Chunder N, Chen C, Umetsu SE, Winandy S, et al. (2007) Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol 179: 7305-7315.
14. Quirion MR, Gregory GD, Umetsu SE, Winandy S, Brown MA, (2009) Cutting edge: Ikaros is a regulator of Th2 cell differentiation. J Immunol 182: 741-745.
15. Umetsu SE, Winandy S, (2009) Ikaros is a regulator of Il10 expression in CD4+ T cells. J Immunol 183: 5518-5525.
16. Pan F, Yu H, Dang EV, Barbi J, Pan X, et al. (2009) Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325: 1142-1146.
17. Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, et al. (2010) A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol 47: 1595-1600.
18. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
19. Quintana FJ, Jin H, Burns EJ, Nadeau M, Yeste A, et al. (2012) Aiolos promotes T(H)17 differentiation by directly silencing Il2 expression. Nat Immunol.
20. Doering TA, Crawford A, Angelosanto JM, Paley MA, Ziegler CG, et al. (2012) Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8(+) T Cell Exhaustion versus Memory. Immunity 37: 1130-1144.
21. Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, et al. (2002) The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell 10: 1403-1415.
22. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
23. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM, (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
24. Kathrein KL, Lorenz R, Innes AM, Griffiths E, Winandy S, (2005) Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol 25: 1645-1654.
25. Zhang Z, Swindle CS, Bates JT, Ko R, Cotta CV, et al. (2007) Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood 109: 2190-2197.
26. Naviaux RK, Costanzi E, Haas M, Verma IM, (1996) The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 70: 5701-5705.
27. Grossel MJ, Baker GL, Hinds PW, (1999) cdk6 can shorten G(1) phase dependent upon the N-terminal INK4 interaction domain. J Biol Chem 274: 29960-29967.
28. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, et al. (2011) A human memory T cell subset with stem cell-like properties. Nat Med 17: 1290-1297.
29. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205: 625-640.
30. McClintick JN, Edenberg HJ, (2006) Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics 7: 49.
31. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
32. Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, et al. (2001) Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 108: 871-878.
33. Depper JM, Leonard WJ, Drogula C, Kronke M, Waldmann TA, et al. (1985) Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A 82: 4230-4234.
34. Acacia de Sa Pinheiro A, Morrot A, Chakravarty S, Overstreet M, Bream JH, et al. (2007) IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells. J Leukoc Biol 81: 1102-1110.
35. Whitmire JK, Tan JT, Whitton JL, (2005) Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med 201: 1053-1059.
36. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
37. Schmidt CS, Mescher MF, (2002) Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. J Immunol 168: 5521-5529.
38. Berg RE, Cordes CJ, Forman J, (2002) Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol 32: 2807-2816.
39. Raue HP, Brien JD, Hammarlund E, Slifka MK, (2004) Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol 173: 6873-6881.
40. Tough DF, Zhang X, Sprent J, (2001) An IFN-gamma-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-gamma. J Immunol 166: 6007-6011.
41. Wherry EJ, (2011) T cell exhaustion. Nat Immunol 12: 492-499.
42. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
43. Fearon DT, Manders P, Wagner SD, (2001) Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293: 248-250.
44. Ahmed R, Bevan MJ, Reiner SL, Fearon DT, (2009) The precursors of memory: models and controversies. Nat Rev Immunol 9: 662-668.
45. Thaventhiran JE, Hoffmann A, Magiera L, de la Roche M, Lingel H, et al. (2012) Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell. Proc Natl Acad Sci U S A.
46. D'Cruz LM, Rubinstein MP, Goldrath AW, (2009) Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin Immunol 21: 92-98.
47. Ichii H, Sakamoto A, Hatano M, Okada S, Toyama H, et al. (2002) Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat Immunol 3: 558-563.
48. Welsh RM, (2009) Blimp hovers over T cell immunity. Immunity 31: 178-180.
49. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, et al. (2003) Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302: 1041-1043.
50. Cannarile MA, Lind NA, Rivera R, Sheridan AD, Camfield KA, et al. (2006) Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat Immunol 7: 1317-1325.
51. Zhou X, Yu S, Zhao DM, Harty JT, Badovinac VP, et al. (2010) Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity 33: 229-240.
52. Manders PM, Hunter PJ, Telaranta AI, Carr JM, Marshall JL, et al. (2005) BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. Proc Natl Acad Sci U S A 102: 7418-7425.
53. Zhu Y, Ju S, Chen E, Dai S, Li C, et al. (2010) T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol 185: 3174-3183.
54. Kim J, Sif S, Jones B, Jackson A, Koipally J, et al. (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345-355.
55. Winandy S, Wu P, Georgopoulos K, (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
56. Sun L, Heerema N, Crotty L, Wu X, Navara C, et al. (1999) Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 96: 680-685.
57. Trinchieri G, (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
58. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF, (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182: 2786-2794.
59. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, et al. (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178: 1223-1230.
60. Fallarino F, Uyttenhove C, Boon T, Gajewski TF, (1996) Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J Immunol 156: 1095-1100.
61. Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, et al. (1996) IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J Immunol 156: 3357-3365.
62. Zhang L, Kerkar SP, Yu Z, Zheng Z, Yang S, et al. (2011) Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol Ther 19: 751-759.
63. Pegram HJ, Lee JC, Hayman EG, Imperato GH, Tedder TF, et al. (2012) Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119: 4133-4141.
64. Yap WH, Yeoh E, Tay A, Brenner S, Venkatesh B, (2005) STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells. FEBS Lett 579: 4470-4478.
65. Thomas RM, Chen C, Chunder N, Ma L, Taylor J, et al. (2010) Ikaros silences T-bet expression and interferon-gamma production during T helper 2 differentiation. J Biol Chem 285: 2545-2553.
66. Williams MA, Tyznik AJ, Bevan MJ, (2006) Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441: 890-893.
67. Pearce EL, Shen H, (2007) Generation of CD8 T cell memory is regulated by IL-12. J Immunol 179: 2074-2081.
68. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, et al. (2010) Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32: 91-103.
69. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010) Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32: 79-90.
70. Malek TR, Castro I, (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33: 153-165.